Grace Therapeutics Announces $10 Million Private Placement
Grace Therapeutics secured approximately $10 million in gross proceeds through a private placement of 4.76 million shares at a price of $2.10 per share. The financing extends the company's cash runway to the end of 2028, providing capital to support manufacturing and regulatory work for its lead asset GTx-104.
Key figures
- Deal Value Usd
- 10000000
- Offering Price
- 2.1
- Shares Offered
- 4761904
- Cash runway
- end of calendar 2028
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.